Advanced Machine Intelligence Labs, founded by Yann LeCun and other ex-Meta researchers, has raised more than $1 billion from investors. By Cade Metz Reporting from San Francisco Late last year, Yann ...

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

Engineers leverage both device-specific and tool-level data to identify a process “sweet spot.” Tight, frequent tool-to-tool matching enables greater yield and fab flexibility. Machine learning helps ...

Apple M5 Max raises memory bandwidth to 614 GB/s; up 13% over M4 Max, improving large-model loading and data-heavy workflows.

AMI Labs, the new venture cofounded by Turing Prize winner Yann LeCun after he left Meta, has raised $1.03 billion at a $3.5 billion pre-money valuation.

What’s the first thing you think of when you hear about ai security threats and vulnerabilities? If you’re like most people, your mind probably jumps to Large Language Model (LLM) ...

Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits and suddenly, a molecule makes a promising new medicine.

I read all 68 pages of the patent behind Ben Affleck’s stealth AI start-up that Netflix just bought in order to understand exactly how the system works (and so you don't have to).

Every few years, the agricultural technology sector gets a new silver bullet. In 2013, the narrative was big data transforming farm management — Monsanto's $1.1 billion acquisition of The Climate ...

A class action lawsuit against UnitedHealthcare claims that an AI system was used to unfairly deny post-acute rehabilitation ...

Researchers developed a machine-learning workflow that predicts how chemical reactions will form specific “handed” versions of molecules—critical for safe and effective drugs. Trained on small ...